ARCHIVES

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

This article is from The Cancer Letter archive.

Vol. 31 No. 19 | May 13, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Former PHS Official Jeffrey Koplan To Head CDC; Caligiuri Wins Freireich Award

July 17, 1998

Surveillance Treatment Option For Low-Risk Prostate Cancer

July 30, 2010

Cancer Act Pulled Entire NIH Budget Up, Schmidt Says

July 20, 1984

ASCO Annual Meeting Attendance Tops 25,000, Continuing Fast Growth.

May 18, 2001

Program Announcement Completes NCI switch To Control Research

April 16, 1982

NCI Drops Breast Screening Guidelines, Issues “Summary Of Scientific Fact”

December 10, 1993